Takuya Akahane
Teikyo University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takuya Akahane.
International Journal of Colorectal Disease | 2012
Soichiro Ishihara; Toshiaki Watanabe; Takuya Akahane; Ryu Shimada; Atsushi Horiuchi; Hajime Shibuya; Tamuro Hayama; Hideki Yamada; Keijiro Nozawa; Keiji Matsuda; K. Maeda; Kenichi Sugihara
PurposeCancers which arise in the proximal and distal colon are suggested to be different clinically, pathologically, and genetically. The aim of this study is to clarify whether clinical behavior of colonic poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-cell carcinoma (Por/Muc/Sig cancers), minor and aggressive subpopulation in colonic cancers, differs in accordance with the tumor location.MethodsA total of 3,175 patients with curatively resected colonic cancers were studied. Clinical and pathological features were compared between Por/Muc/Sig cancers and well or moderately differentiated adenocarcinomas (Wel/Mod cancers) and between proximal and distal cancers in each histologic type.ResultsPor/Muc/Sig cancers (n = 213) were more advanced in the TNM stage and showed worse disease-specific survival than Wel/Mod cancers (n = 2,692). In Por/Muc/Sig cancers, but not in Wel/Mod cancers, proximal cancers showed significantly better disease-specific survival than distal cancers (88.9% vs. 76.5%, p = 0.0234), and a multivariate analysis showed that proximal tumor location was an independent predictor of fair prognosis (hazard ratio (HR), 0.458; 95% confidence interval (CI), 0.218–0.961; p = 0.0390). In addition, female gender also was an independent predictor of fair prognosis in Por/Muc/Sig cancers (HR, 0.373; 95% CI, 0.151–0.922) and not in Wel/Mod cancers.ConclusionsProximal Por/Muc/Sig cancers were suggested to be a distinct subpopulation with a favorable oncologic outcome. Tumor location and gender might be helpful in the risk stratification after curative surgery for Por/Muc/Sig cancers.
International Surgery | 2011
Hideki Yamada; Takuya Akahane; Atsushi Horiuchi; Ryu Shimada; Hajime Shibuya; Tamuro Hayama; Keijirou Nozawa; S. Ishihara; Keiji Matsuda; Toshiaki Watanabe
Gastrointestinal metastasis of lung cancer is fairly rare, and metastasis to the duodenum is very uncommon. We report a case of duodenum and small intestine metastases of lung squamous cell carcinoma. The patient was a 66-year-old man. He was diagnosed with lung squamous cell carcinoma (T4N3M1 [mediastinum, cervical lymph node, and duodenum metastases], stage IV). He noted a sense of abdominal fullness on the evening of the day chemoradiotherapy was given, and emergency surgery was performed for suspected perforation of the digestive tract. Intraoperative findings included a tumor in the small intestine with a perforation at the tumor site; partial resection of the small intestine, including the tumor, was performed. Small intestine metastasis of lung cancer was diagnosed following histopathologic examination. When lung cancer patients complain of abdominal symptoms, it is important to consider gastrointestinal metastases in diagnosis and treatment.
International Surgery | 2011
Atsushi Horiuchi; Keijiro Nozawa; Takuya Akahane; Ryu Shimada; Hajime Shibuya; Yoshiko Aoyagi; Keisuke Nakamura; Tamuro Hayama; Hideki Yamada; Soichiro Ishihara; Keiji Matsuda; Toshiaki Watanabe
Skin metastases from visceral cancers are rare and the reported incidence from all visceral cancers is 1.4% to 10%. Skin metastases from colorectal cancers account for only 5% of metastatic skin cancers, among which scalp metastases are very rare. We describe a 53-year-old man with scalp metastasis derived from sigmoid colon cancer that was diagnosed and surgically resected in 2005. Metastatic lung tumors that developed thereafter were surgically resected and then chemotherapy was administered. However, metastatic brain tumors occurred in 2008, and these were treated by gamma-knife radiosurgery. Around the same time, a raised lesion that appeared on the scalp was diagnosed as skin metastasis and treated with best supportive care. Thereafter, the brain metastases continued to spread, and the patient died in October 2008.
International Surgery | 2011
Tamuro Hayama; Soichiro Ishihara; Norihito Yamazaki; Takuya Akahane; Ryu Shimada; Atsushi Horiuchi; Hajime Shibuya; Hideki Yamada; Keijiro Nozawa; Keiji Matsuda; Toshiaki Watanabe
One rare complication of a ventriculoperitoneal (VP) shunt is perforation of the gastrointestinal tract by the catheter. We report a case in which the catheter severed spontaneously inside the peritoneal cavity, creating a communication between the intestinal tract and the peritoneal cavity. The patient was a 41-year-old man who presented with a VP shunt catheter protruding from the anus. Computed tomography showed that the VP shunt catheter, which had been put in place 25 years earlier, had severed spontaneously. The distal end had then perforated and entered the intestinal tract. The patient was hospitalized and emergency surgery was performed to repair the intestinal tract perforation caused by the end of the VP shunt catheter. Laparotomy revealed that the catheter had perforated the sigmoid colon. The VP shunt catheter was removed, and the perforation in the intestinal tract was closed by suturing. The patient was discharged on postoperative day 20.
Biomedical Research and Clinical Practice | 2017
Keiji Matsuda; Keijiro Nozawa; Kohei Ohno; Yuka Okada; Takahiro Yagi; Mitsuo Tsukamoto; Yoshihisa Fukushima; Takuya Akahane; Atsushi Horiuchi; Ryu Shimada; Tamuro Hayama; Koichi Okamoto; Takeshi Tsuchiya; Junko Tamura; Hisae Iinuma; Yuko Sasajima; Fukuo Kondo; Shoichi Fujii; Y. Hashiguchi
Objectives: TAS-102 and regorafenib are novel antineoplastic drugs recommended for salvage-line chemotherapy. The objective of this study was to elucidate useful markers with predictive values for the effectiveness of these drugs. Methods: Between August 2013 and April 2016, 23 patients with refractory colorectal cancer received salvage-line chemotherapy at Teikyo University Hospital, Japan. 15 patients received TAS-102 monotherapy and 15 received regorafenib, including seven who had dual therapies. Tumor markers were analyzed for possible correlations with tumor response and the patients’ prognoses after these treatments. Results: Twelve patients of each group had radiologically measurable tumors. None of the TAS-102-treated patients achieved complete response (CR) or partial response (PR). After regorafenib therapy, no patients achieved CR, but one (8%) patient showed PR. These and the lack of correlation between the tumor responses and the patients’ overall survival (OS) suggested a limited predictive value of RECIST-based tumor evaluation in our study. Nonetheless, the OS of the patients with a decreased CA19-9 level after initial treatment with TAS-102 tended to be longer than that of the patients with an increased CA19-9 level (p=0.058). The OS of the patients with decreased CEA after initial regorafenib treatment was significantly longer than that of patients with increased CEA (p=0.03). Conclusions: The results of the present analysis suggest that CEA and CA19-9 may be more practical and useful as predictive/prognostic markers for refractory CRC patients treated with TAS-102 and regorafenib even when the predictive value of the tumor response measured using RECIST is not clear. Correspondence to: Keiji Matsuda, M.D., Ph.D., The Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, Japan, Tel: 81-3-3964-1211; Fax: 81-3-5375-6097; E-mail: [email protected]
International Surgery | 2011
Hideki Yamada; S. Ishihara; Takuya Akahane; Ryu Shimada; Atsushi Horiuchi; Hajime Shibuya; Yoshiko Aoyagi; Keisuke Nakamura; Hisae Iinuma; Tamuro Hayama; Keijirou Nozawa; Keiji Matsuda; Toshiaki Watanabe
Williams syndrome is rare and associated with physical anomalies and mental retardation. It is a disease resulting from a gene deletion of chromosome 7. The main concurrent medical conditions typically associated with Williams syndrome are heart defects such as supravalvular aortic stenosis, mental retardation, and unusual physical characteristics. It is also associated with colon diverticulosis and diverticulitis. In the present article, we report on 2 cases of diverticulitis in patients with Williams syndrome, in whom surgery was performed. In many cases of diverticulitis in patients with Williams syndrome, surgical treatment is indicated. It is important to take diverticulitis into consideration when examining a patient with Williams syndrome presenting with abdominal pain and consider surgical treatment if necessary.
International Surgery | 2011
Ryu Shimada; Tamuro Hayama; Norihito Yamazaki; Takuya Akahane; Atushi Horiuchi; Hajime Shibuya; Hideki Yamada; Soichiro Ishihara; Keijiro Nozawa; Keiji Matsuda; Toshiaki Watanabe
Intestinal pneumatosis refers to the presence of gas in the gastrointestinal wall. It is often difficult to clinically differentiate this condition from gastrointestinal perforation, sometimes resulting in emergency surgery. Imaging studies are important to establish the differential diagnosis. However, there have been few studies showing the efficacy of computed tomography (CT) colonography in diagnosing pneumatosis. We report a case of intestinal pneumatosis in which CT colonography was of significant diagnostic value. A 43-year-old man was referred to our hospital for a detailed investigation of multiple submucosal tumor-like lesions associated with multiple pneumatosis from the cecum to the ascending colon. These lesions were revealed by colonoscopy performed in another hospital on May 21, 2008. Abdominal 3-dimensional CT showed multiple pneumatic lesions from the cecum to the ascending colon, and the patient was diagnosed as having intestinal pneumatosis. The patient is being followed conservatively because he is asymptomatic.
International Surgery | 2011
Atsushi Horiuchi; Keiji Matsuda; Takuya Akahane; Ryu Shimada; Hajime Shibuya; Tamuro Hayama; Hideki Yamada; S. Ishihara; Keijirou Nozawa; Toshiaki Watanabe
A 67-year-old man had rectal cancer with para-aortic lymph node metastasis. Prior to surgical resection, tegafur-uracil and leucovorin had been administered orally as chemotherapy, and radiotherapy (50.4 Gy) was applied for the rectum and para-aortic lymph nodes. Low anterior resection was then performed, followed by 45 cycles of chemotherapy in total. Enlargement of the left axillary lymph nodes was noted during treatment, but nodes shrank in response to treatment with bevacizumab + FOLFIRI (i.e., irinotecan + 5-fluorouracil/leucovorin). As of the time of writing, 36 months after diagnosis, no swelling of the para-aortic lymph nodes was evident and chemotherapy was being continued. This patient was alive after achieving response to neoadjuvant therapy comprising chemotherapy and irradiation of the para-aortic lymph nodes, along with postoperative chemotherapy. This therapeutic approach of preoperative chemotherapy plus irradiation of the primary lesion and para-aortic lymph nodes has potential as an effective treatment.
Oncology Reports | 2012
Ryu Shimada; Hisae Iinuma; Takuya Akahane; Atsushi Horiuchi; Toshiaki Watanabe
Oncology Reports | 2012
Atsushi Horiuchi; Hisae Iinuma; Takuya Akahane; Ryu Shimada; Toshiaki Watanabe